|
Delayed
Nasdaq
08:31:31 11/09/2026 pm IST
|
5-day change | 1st Jan Change | ||
| 6.815 USD | +1.11% |
|
+5.36% | -11.14% |
| 16/25/16 | Crescent Biopharma Completes Merger With GlycoMimetics | MT |
| 30/23/30 | Catalyst Biosciences, Inc.(NasdaqCM:CBIO) dropped from NASDAQ Composite Index | CI |
Chart: Technical Analysis
NasdaqUSD
| Markets | Quality | ||
|---|---|---|---|
Deutsche Boerse AG
| HGF2 | Delayed |
Technical analysis trends
| Short Term | Mid-Term | Long Term | |
|---|---|---|---|
| Trend | Neutral | Neutral | Neutral |
| Resistance | 8.25 | 9.72 | 9.6 |
| Spread/Res. | -17.39% | -29.89% | -29.01% |
| Spread/Supp. | +34.50% | +116.35% | +132.28% |
| Support | 5.067 | 3.15 | 2.934 |
- Stock Market
- Stocks
- CBIO Stock
- Charts Catalyst Biosciences
Select your edition
All financial news and data tailored to specific country editions
